IVIM Technology, Inc (KOSDAQ:460470)
South Korea · Delayed Price · Currency is KRW 3,000.00
-180.00 (-5.66%)
Aug 11, 2026, 3:30 PM KST
IVIM Technology Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,303 | 4,376 | 3,564 | 4,495 | 1,338 | 526.97 |
Revenue Growth | 19.02% | 22.77% | -20.71% | 235.98% | 153.88% | - |
Gross Profit Gross Profit Growth | 980 | 1,037 | 1,214 | 1,388 | 128.31 | -192.84 |
Operating Income Operating Income Growth | -4,089 | -4,153 | -4,309 | -2,905 | -3,331 | -2,678 |
Net Income Net Income Growth | -3,755 | -3,803 | -4,003 | -5,044 | -9,735 | -2,621 |
Earnings Per Share EPS Growth | -248.84 | -251.92 | -293.00 | -660.00 | -1947.00 | -13103.03 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Biomicroscope Biomicroscope Growth | 2,810 | 3,747 | 1,077 | 300.27 |
Contract Research Organization Services Contract Research Organization Services Growth | 442.45 | 280.53 | 176.89 | 203.2 |
Imaging Accessories Imaging Accessories Growth | 70.6 | 10.26 | - | - |
Other Other Growth | 241.63 | 457.54 | 84.45 | 23.5 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 14,525 | 15,611 | 22,548 | 8,057 | 11,993 | 1,358 |
Total Debt Total Debt Growth | 1,590 | 1,649 | 2,274 | 2,427 | 11,311 | 2,389 |
Net Cash (Debt) Net Cash Growth | 12,935 | 13,962 | 20,274 | 5,629 | 681.81 | -1,031 |
Net Cash Growth | -29.70% | -31.13% | 260.14% | 725.66% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 857.31 | 924.96 | 1483.78 | 736.67 | 136.36 | -5154.47 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3,565 | -4,247 | -6,930 | -3,446 | -4,083 | -3,531 |
Capital Expenditures CapEx Growth | -2,100 | -2,453 | -432.33 | -489.92 | -403.91 | -1,252 |
Free Cash Flow Free Cash Flow Growth | -5,665 | -6,699 | -7,363 | -3,936 | -4,487 | -4,783 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 22.78% | 23.69% | 34.06% | 30.88% | 9.59% | -36.59% |
Operating Margin | -95.05% | -94.91% | -120.91% | -64.63% | -248.95% | -508.10% |
Pretax Margin | -87.26% | -86.90% | -112.32% | -112.20% | -727.66% | -497.27% |
Profit Margin | -87.26% | -86.90% | -112.32% | -112.20% | -727.66% | -497.27% |
FCF Margin | -131.67% | -153.10% | -206.57% | -87.56% | -335.35% | -907.62% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 11.17 | 11.35 | 20.23 | - | - | - |